pcDNA3-HA-RIPK3 Citations (2)
Originally described in: CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3.Seo J, Lee EW, Sung H, Seong D, Dondelinger Y, Shin J, Jeong M, Lee HK, Kim JH, Han SY, Lee C, Seong JK, Vandenabeele P, Song J Nat Cell Biol. 2016 Mar;18(3):291-302. doi: 10.1038/ncb3314. Epub 2016 Feb 22. PubMed Journal
Articles Citing pcDNA3-HA-RIPK3
Articles |
---|
Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome. Tapiz I Reula AJ, Cochino AV, Martins AL, Angosto-Bazarra D, de Landazuri IO, Mensa-Vilaro A, Cabral M, Baroja-Mazo A, Banos MC, Lobato-Salinas Z, Fabregat V, Plaza S, Yague J, Casals F, Oliva B, Figueiredo AE, Pelegrin P, Arostegui JI. J Clin Immunol. 2022 Jun 18. pii: 10.1007/s10875-022-01298-2. doi: 10.1007/s10875-022-01298-2. PubMed |
OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis. Lee SA, Chang LC, Jung W, Bowman JW, Kim D, Chen W, Foo SS, Choi YJ, Choi UY, Bowling A, Yoo JS, Jung JU. Nat Cell Biol. 2023 Jan;25(1):92-107. doi: 10.1038/s41556-022-01039-y. Epub 2023 Jan 5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.